• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ:QNTM)

    2.970 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 173
    Open 2.970
    Bid (Size) 2.750 (100)
    Ask (Size) 3.450 (100)
    Prev. Close 2.970
    Today's Range 2.970 - 2.970
    52wk Range 2.070 - 31.91
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Executive Outlines Lucid-MS Development Strategy and Commercial Growth Plans
    Via Investor Brand Network
    Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions
    Via Investor Brand Network

    Performance

    YTD
    -57.6%
    -57.6%
    1 Month
    -19.7%
    -19.7%
    3 Month
    -33.3%
    -33.3%
    6 Month
    -44.9%
    -44.9%
    1 Year
    -88.1%
    -88.1%

    More News

    Read More
    Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Hits Key Study Milestone as Early MS Imaging Data Shows Promising Signal
    Via Investor Brand Network
    InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy
    Via Investor Brand Network
    MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy
    Via Investor Brand Network
    BioMedNewsBreaks — Why Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Is ‘One to Watch’
    Via Investor Brand Network
    Topics Intellectual Property
    Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast
    Via Investor Brand Network
    Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study
    Via Investor Brand Network
    NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in NetworkNewsAudio Editorial on Multiple Sclerosis
    Via Investor Brand Network
    News headline image
    NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis
    From NetworkNewsWire
    Via GlobeNewswire
    BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial on Multiple Sclerosis Treatment
    Via Investor Brand Network
    News headline image
    Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
    From Quantum BioPharma Ltd.
    Via GlobeNewswire
    The Quest to Repair What Multiple Sclerosis Takes Away
    Via Investor Brand Network
    InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
    Via Investor Brand Network
    News headline image
    The Quest to Repair What Multiple Sclerosis Takes Away
    From BioMedWire
    Via GlobeNewswire
    BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial on Lucid-MS Program
    Via Investor Brand Network
    News headline image
    Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
    From Quantum BioPharma Ltd.
    Via GlobeNewswire
    MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
    Via Investor Brand Network
    Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
    Via Investor Brand Network
    News headline image
    Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
    From BioMedWire
    Via GlobeNewswire
    Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for Multiple Sclerosis Treatment
    Via Investor Brand Network
    Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets
    Via Investor Brand Network
    InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Engages Stocks.news for Investor Relations Services
    Via Investor Brand Network
    MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast
    Via Investor Brand Network
    BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast
    Via Investor Brand Network

    Frequently Asked Questions

    Is Quantum Biopharma Ltd. - Class B Subordinate Voting Shares publicly traded?
    Yes, Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is publicly traded.
    What exchange does Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trade on?
    Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
    The ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is QNTM on the Nasdaq Stock Market
    What is the current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
    The current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is 2.970
    When was Quantum Biopharma Ltd. - Class B Subordinate Voting Shares last traded?
    The last trade of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares was at 07/27/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.